Position in AZN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$281,016
+$570 QoQ
Shares Held
1,482
+4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,069
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Encompass More Asset Management holds $2,871,318 across 7 Drug Manufacturers - General names. AZN ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
14,408 | $830,188 | |
| 2 | JNJ |
Johnson & Johnson
|
2,525 | $641,274 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
2,935 | $370,807 | |
| 4 | ABBV |
AbbVie Inc.
|
1,118 | $281,333 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,482 | $281,016 | |
| 6 | AMGN |
Amgen Inc
|
682 | $246,965 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,710 | $219,735 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $281,016 | 1,482 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $280,446 | 1,422 | Shares | Sole | 2026-04-28 | |
| No filing history on record for this holder in this stock. | ||||||